In an industry where speed to market is crucial and expertise pivotal, XenoTech developed a niche drug development service – next IND – based on a partnership of highly experienced and specialized companies. Partners include Cedarburg Hauser, XenoTech, Formurex, Xenometrics, KCAS and Vince & Associates. With such focused expertise, next IND had a strong concept that needed to be paired with a strong brand image, messaging and a marketing plan to launch awareness.
Rhycom partnered with the six companies that make up the next IND consortium to develop a name and logo. With next IND established, Rhycom moved on to develop further branding and messaging as well as marketing materials including a sales brochure, infographics, website, an email template, conference booth graphics and a website.